| Mrs Deana Teplitsky Nes, DO | |
|
466 Old Hook Rd Ste 1, Emerson, NJ 07630-1368 | |
| (201) 967-8221 | |
| Not Available |
| Full Name | Mrs Deana Teplitsky Nes |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 10 Years |
| Location | 466 Old Hook Rd Ste 1, Emerson, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851710040 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 25MB10597400 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hackensack Meridian Health Pascack Valley Medical | Westwood, NJ | Hospital |
| Hackensack University Medical Center | Hackensack, NJ | Hospital |
| Valley Hospital | Ridgewood, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mpv New Jersey Md Services Pc | 5991097669 | 120 |
News Archive
Ranbaxy Laboratories Limited today announced the launch of Letrozole Tablets 2.5 mg in UK, Romania and France, on Day-1. Letrozole is the bio equivalent of Femara, the innovator product of Novartis, that has a market size of USD 58 Mn in UK, USD 95 Mn in France and USD 5.5 Mn in Romania.
Smokers who try to quit would be more successful if they combined medication or nicotine-replacement therapy with behavioral counseling, finds a new review in The Cochrane Library. Few lifestyle changes deliver as many positive health benefits as quitting smoking, including improved circulation, lowered blood pressure and a decreased risk of cancer and heart disease.
Results from a large international clinical study reported in this week's issue of The Lancet showed that peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B. The investigator-initiated study is the largest clinical trial to date with peginterferon alfa-2b therapy for chronic hepatitis B.
TeleHealth Services, the nation's leading provider of hospital televisions and interactive patient engagement solutions, announced through their partnership with Samsung Electronics America, Inc., the completion of a new patient engagement solution called SmarTigr.
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version for Bayer Healthcare Pharmaceuticals' oral contraceptive Yaz® (Drospirenone and Ethinyl Estradiol) Tablets.
› Verified 7 days ago
| Entity Name | Mpv New Jersey Md Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215391271 PECOS PAC ID: 5991097669 Enrollment ID: O20160718000760 |
News Archive
Ranbaxy Laboratories Limited today announced the launch of Letrozole Tablets 2.5 mg in UK, Romania and France, on Day-1. Letrozole is the bio equivalent of Femara, the innovator product of Novartis, that has a market size of USD 58 Mn in UK, USD 95 Mn in France and USD 5.5 Mn in Romania.
Smokers who try to quit would be more successful if they combined medication or nicotine-replacement therapy with behavioral counseling, finds a new review in The Cochrane Library. Few lifestyle changes deliver as many positive health benefits as quitting smoking, including improved circulation, lowered blood pressure and a decreased risk of cancer and heart disease.
Results from a large international clinical study reported in this week's issue of The Lancet showed that peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B. The investigator-initiated study is the largest clinical trial to date with peginterferon alfa-2b therapy for chronic hepatitis B.
TeleHealth Services, the nation's leading provider of hospital televisions and interactive patient engagement solutions, announced through their partnership with Samsung Electronics America, Inc., the completion of a new patient engagement solution called SmarTigr.
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version for Bayer Healthcare Pharmaceuticals' oral contraceptive Yaz® (Drospirenone and Ethinyl Estradiol) Tablets.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Deana Teplitsky Nes, DO 466 Old Hook Rd Ste 1, Emerson, NJ 07630-1368 Ph: (201) 967-8221 | Mrs Deana Teplitsky Nes, DO 466 Old Hook Rd Ste 1, Emerson, NJ 07630-1368 Ph: (201) 967-8221 |
News Archive
Ranbaxy Laboratories Limited today announced the launch of Letrozole Tablets 2.5 mg in UK, Romania and France, on Day-1. Letrozole is the bio equivalent of Femara, the innovator product of Novartis, that has a market size of USD 58 Mn in UK, USD 95 Mn in France and USD 5.5 Mn in Romania.
Smokers who try to quit would be more successful if they combined medication or nicotine-replacement therapy with behavioral counseling, finds a new review in The Cochrane Library. Few lifestyle changes deliver as many positive health benefits as quitting smoking, including improved circulation, lowered blood pressure and a decreased risk of cancer and heart disease.
Results from a large international clinical study reported in this week's issue of The Lancet showed that peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B. The investigator-initiated study is the largest clinical trial to date with peginterferon alfa-2b therapy for chronic hepatitis B.
TeleHealth Services, the nation's leading provider of hospital televisions and interactive patient engagement solutions, announced through their partnership with Samsung Electronics America, Inc., the completion of a new patient engagement solution called SmarTigr.
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted approval for the Company's Abbreviated New Drug Application (ANDA) to market its generic version for Bayer Healthcare Pharmaceuticals' oral contraceptive Yaz® (Drospirenone and Ethinyl Estradiol) Tablets.
› Verified 7 days ago
Tracy Lynne Walker, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 466 Old Hook Rd Ste 1, Emerson, NJ 07630 Phone: 201-967-8221 | |
Dr. Holly Cullen, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 466 Old Hook Rd, Suite 1, Emerson, NJ 07630 Phone: 201-967-8221 | |
Amy G Ali, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 452 Old Hook Rd, 2nd Floor, Emerson, NJ 07630 Phone: 201-666-3900 Fax: 201-261-0505 | |
Dr. Robert H Pittman, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 466 Old Hook Rd, Suite 1, Emerson, NJ 07630 Phone: 201-967-8221 Fax: 201-634-9647 | |
Dr. David Goldstein, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 452 Old Hook Rd, 2nd Floor, Emerson, NJ 07630 Phone: 201-666-3900 Fax: 201-261-0505 | |
Dr. Jeffrey S. Kim, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 466 Old Hook Rd, Suite 26, Emerson, NJ 07630 Phone: 201-261-0821 Fax: 201-261-0823 | |
Sandeep Kour, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 466 Old Hook Rd Ste 1, Emerson, NJ 07630 Phone: 201-967-8221 |